Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

44.63 8.65 −16.23%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a P/B ratio of 1.1×. Over the past ten years it has ranged from 1.1× (November 2026) to 4.2× (November 2015) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 1.8× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 1.5× (34.65%)
FY2025 2.3× 8.05%
FY2024 2.2× (0.20%)
FY2023 2.2× 28.03%
FY2022 1.7× 3.50%
FY2021 1.6× 2.55%
FY2020 1.6× 13.93%
FY2019 1.4× (6.19%)
FY2018 1.5× (58.45%)
FY2017 3.6× (5.44%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 1.1× (4.29%)
Jun 2026 1.2× (23.07%)
Mar 2026 1.5× (5.75%)
Dec 2025 1.6× (3.69%)
43 more quarters

Against its own ten years

Low 1.1× High 4.2×
Ten-year median 1.9×
Current reading's percentile 0

P/B ratio against peers

Company P/B ratio
BCRX BioCryst Pharmaceuticals, Inc. compare n/m
ALVO Alvotech compare n/m
RGC Regencell Bioscience Holdings Limited compare n/m
HCM HUTCHMED (China) Limited Sponsored ADR compare n/m
PRGO Perrigo Company plc compare 0.9×
PBH Prestige Consumer Healthcare Inc. 1.1×
TRLV Trulieve Cannabis Corp. compare 2.8×
AMLX Amylyx Pharmaceuticals, Inc. compare 12.9×
XERS Xeris Biopharma Holdings, Inc. compare 48.0×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PBH